Karyopharm Therapeutics (25K0.F) Q2 2025 Earnings

12MayConfirmed
Q1 2025
Q2 2025
-3.98
-3.49
-2.99
-2.5

Details

Expected EPS
-3.9824837717599997
Actual EPS
-2.4962131999999997
Surprise EPS
1.49
Surprise Percent
+37.32%

Description

Karyopharm Therapeutics (25K0.F) has reported earnings of -2.4962131999999997 per share for Q2 2025.

0 Comments

Share your thoughts